Cargando…
Neurological disease in xeroderma pigmentosum: prospective cohort study of its features and progression
Xeroderma pigmentosum (XP) results from biallelic mutations in any of eight genes involved in DNA repair systems, thus defining eight different genotypes (XPA, XPB, XPC, XPD, XPE, XPF, XPG and XP variant or XPV). In addition to cutaneous and ophthalmological features, some patients present with XP n...
Autores principales: | Garcia-Moreno, Hector, Langbehn, Douglas R, Abiona, Adesoji, Garrood, Isabel, Fleszar, Zofia, Manes, Marta Antonia, Morley, Ana M Susana, Craythorne, Emma, Mohammed, Shehla, Henshaw, Tanya, Turner, Sally, Naik, Harsha, Bodi, Istvan, Sarkany, Robert P E, Fassihi, Hiva, Lehmann, Alan R, Giunti, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690019/ https://www.ncbi.nlm.nih.gov/pubmed/38040034 http://dx.doi.org/10.1093/brain/awad266 |
Ejemplares similares
-
Xeroderma pigmentosum is a definite cause of Huntington's disease‐like syndrome
por: Garcia‐Moreno, Hector, et al.
Publicado: (2017) -
Xeroderma pigmentosum
por: Lehmann, Alan R, et al.
Publicado: (2011) -
Dramatic response of metastatic cutaneous angiosarcoma to an immune checkpoint inhibitor in a patient with xeroderma pigmentosum: whole-genome sequencing aids treatment decision in end-stage disease
por: Momen, Sophie, et al.
Publicado: (2019) -
Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigmentosum patients with metastatic or unresectable cancers
por: Fernandez, Elvelyn R., et al.
Publicado: (2023) -
Xeroderma Pigmentosum
por: Srivastava, Gautam, et al.
Publicado: (2021)